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a b s t r a c t
Cardioviruses of the Encephalomyocarditis virus (EMCV) and Theilovirus species encode small, amino-
terminal proteins called Leaders (L). Phosphorylation of the EMCV L (LE) at two distinct sites by CK2 and
Syk kinases is important for virus-induced Nup phosphorylation and nucleocytoplasmic trafﬁcking
inhibition. Despite similar biological activities, the LE phosphorylation sites are not conserved in the
Theiloviruses, Saffold virus (LS, SafV) or Theiler's murine encephalitis virus (LT, TMEV) sequences even
though these proteins also become phosphorylated in cells and cell-free extracts. Site prediction
algorithms, combined with panels of site-speciﬁc protein mutations now identify analogous, but not
homologous phosphorylation sites in the Ser/Thr and Theilo protein domains of LT and LS, respectively.
In both cases, recombinant AMP-activated kinase (AMPK) was reactive with the proteins at these sites,
and also with LE, modifying the same residue recognized by CK2.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Encephalomyocarditis virus (e.g. EMCV) and Theiloviruses (e.g.
Vilyusik virus, Theiler's murine encephalitis viruses [TMEV], and
Saffold viruses [SafV]) are Cardiovirus species in the Picornaviridae
family. All isolates from this genus have small, Leader proteins
(L) encoded at the amino terminus of their viral polyproteins.
These highly acidic peptides of 67- (EMCV, LE), 71- (SafV, LS) or 76-
(TMEV, LT) amino acids (aa) carry out important anti-host func-
tions. For example, the LE and LT proteins have been attributed
with pro- or anti-apoptotic functions, depending on the viral strain
and cell culture system (Arslan et al., 2012; Stavrou et al., 2011;
Romanova et al., 2009; Okuwa et al., 2010; Ghadge et al., 1998;
Himeda et al., 2005; Carocci et al., 2011). For TMEV (DA), LT
expression in a virus context can inhibit stress granule formation
in the cytoplasm, thereby reducing the turnover of RNA (Borghese
and Michiels, 2011). It is not clear whether all cardioviruses share
all these same pathways, or if these particular effects are just
observed downstream consequences of the major L function, the
common catastrophic inhibition of active cellular nucleo-
cytoplasmic trafﬁcking (Lidsky et al., 2006; Bardina et al., 2009;
Porter and Palmenberg, 2009; Porter et al., 2010; Delhaye et al.,
2004). The introduction of LE, LT or LS into cells by viral or
recombinant means uniformly triggers massive phosphorylation
of Phe/Gly-containing nuclear pore proteins (Nups) (Porter and
Palmenberg, 2009; Ricour et al., 2009; Basta et al., 2014). The
modiﬁed Nups are refractive to cargo-carrying karyopherins
(importins or exportins), halting almost immediately the normal
active nuclear-cytoplasmic transport system for proteins and
RNAs, to a mere trickle allowed by diffusion-only. This unique
cardiovirus phenomenon requires a poorly understood mechanism
involving the binding of L to RanGTPase, followed by activation
and misdirection of a particular cohort of mitogen-activated
protein kinases (MAPKs) (Porter et al., 2010). For EMCV, the best
studied system, MAPKs ERK1/2 and p38, as well as their down-
stream substrates, MAPKAP-2 (MK2) and RSK, become potently
activated in an LE-dependent manner (Porter et al., 2010). Chemi-
cal inhibition of ERK1/2 and p38 pathways abolishes LE-directed
Nup phosphorylation and protects the cells (Porter et al., 2010).
Likewise, LE mutations which prevent RanGTPase interactions or
unfold the protein are unable to trigger Nup phosphorylation
(Bacot-Davis and Palmenberg, 2013).
Despite having identity variations that can exceed 65%, all cardi-
ovirus L proteins are homologs, if not presumed analogs. The LM
(EMCV, Mengo) structure as solved by NMR (PDB: 2M7Y) shows a
ﬂexible coiled-coil conﬁguration distinguished by an unusual,
conserved (genus level) CHCC-based zinc ﬁnger (aa 10–22) near
the amino terminus (Fig. 1). A carboxyl-proximal “acidic” domain
(aa 37–52) is also shared, conferring a pI of 3.6–3.8 to each protein.
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A central linker or hinge region (LE aa 35–40) mediates essential
interactions with cellular binding partner, RanGTPase, presumably
through induced-ﬁt contacts (Bacot-Davis and Palmenberg, 2013).
Theilovirus L proteins have shorter amino-termini, but they are
longer than LE proteins, because of carboxyl-proximal insertions
that add 14- or 19-aa respectively to the LS and LT sequences. The
common portion of these insertions, the “Theilo domain,” is
diagnostic of that species (BeAn aa 60–73). Only the LT display
additional, upstream “Ser/Thr-rich” residues (BeAn aa 51–63).
The indel domain functions have been partially inferred by genetic
mapping with viruses. Point mutations to the LT (DA) Theilo
domain reduce viral apoptotic activity, decrease virus persistence
in FVB/N mice, and reduce Nup98 phosphorylation with conse-
quent decreased inhibition of nucleocytoplasmic trafﬁcking. They
also decrease the ability to inhibit IFN-β and RANTES activities,
and decrease the ability to inhibit IRF-3 dimerization (Ricour et al.,
2009). Such viruses are also unable to inhibit stress granule
formation (Borghese and Michiels, 2011). Equivalent mutations
to the LT Ser/Thr domain (S51A, S53A, and S54A) do not have similar
effects (Ricour et al., 2009), although a single amino acid change in
the LT of GDVII virus (P57) and DA virus (S57) correlates with
differential apoptotic phenotypes (Stavrou et al., 2011), and LT
intracellular localization differences (Taniura et al., 2009).
The problem with evaluating such results is that even point
mutations can have unanticipated long-range effects if they un-
intentionally disrupt protein structure. Moreover, as has been
shown for LE, directed phosphorylation particular to these regions
plays a very important role in the observed activity (Basta et al.,
2014). In cells, LE is sequentially phosphorylated by casein kinase 2
(CK2) and spleen tyrosine kinase (Syk) on T47 and Y41, respectively
(Basta et al., 2014). The reactions are not obligatory for RanGTPase
interactions, but they are essential for the subsequent trigger of
MAPK pathways. LT and LS also become phosphorylated, but at
different sites than LE, and in reactions that do not require CK2
(Basta et al., 2014). Sequence comparisons have suggested S57
(Taniura et al., 2009) and/or T63 (Ricour et al., 2009) as possible
sites in LT (DA). We now have experimental validation that LT
(BeAn) and LS (SafV-2) and are differentially phosphorylated at S57
(Ser/Thr domain) and T58 (Theilo domain), respectively. Both
reactions can be catalyzed by AMP-activated protein kinase
(AMPK), an enzyme that can substitute for CK2 in the initial
phosphorylation of LE. The identiﬁed LS and LT sites have super-
imposable structural locales in an extended helical motif, modeled
for the Ser/Thr and Theilo domain insertions.
Results and discussion
Phosphorylation site mapping
A dataset of cardiovirus L proteins (Fig. 1) was compiled from
GenBank, aligned by ClustalX (Larkin et al., 2007) and is summar-
ized using Weblogo format (Crooks et al., 2004). The LT (BeAn),
LS (SafV-2) and LE (EMCV-R) sequences are those from GenBank
ﬁles, m16020, am922293, and m81861 respectively. Phosphoryla-
tion predictions for these proteins used online program suites,
including PPSP (set to “high sensitivity” for “all kinases”) (Xue et
al., 2006), NetPhosK1.0 (set to “prediction without ﬁltering” (fast),
threshold¼0.5) (Blom et al., 2004), NetPhos2.0 (Blom et al., 1999),
Phosida (Gnad et al., 2011), DiPHOS (speciﬁed predict for viruses)
(Iakoucheva et al., 2004), Phosphomotif Finder (Amanchy et al.,
2007) and ScanSite (set to “low stringency”) (Obenauer, 2003).
For LE (recombinant or viral), CK2 phosphorylation at T47 is
the primary, obligatory event in cells or in vitro, followed by a
Syk reaction at Y41 (Basta et al., 2014). The LT-GST and LS-GST
proteins do not react with CK2 and the required site (T47XXD/E) is
not conserved in this species. Credible alternative predicted
phosphorylation sites, common to each Theilo sequence group
included 6 Tyr/Thr residues in LS, and 8 Tyr/Thr/Ser residues in LT
(ﬁlled symbols in Fig. 1). These, and structurally debilitating (C11)
mutations in the respective zinc ﬁnger domains, were individually
constructed into LT- and LS-GST plasmids. Each protein was
expressed and puriﬁed. When added to HeLa cytosol in the
presence of γ-32P-ATP, all of the LT-GST sequences were labeled,
except C11A, Y7L and S57A (Fig. 2A). Some proteins, especially those
with phosphomimetic glutamate mutations (S51D, T53D, and T59D),
actually registered more strongly than wild-type (wt) when the
signals were normalized (densitometry) to the unmodiﬁed par-
ental fusion protein band (αGST, top band). When this type of
diversity was observed with the LE-GST proteins (Basta et al., 2014)
it was indicative of interdependent phosphorylation events, one of
which (at T47) was an obligatory precursor for the other (at Y41).
The LS-GST proteins (Fig. 2B) had more variable responses.
The wt protein was only weakly labeled in HeLa extracts (Basta et
al., 2014), and all members of this panel incorporated less label than
any reactive LT-GST. The membranes required more than twice the
exposure to even visualize the positive bands. Relative to each
other, the C11A, Y7L, T36A and Y49F sequences were labeled 2–3
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Fig. 1. Cardiovirus Leader sequences. WebLogo depiction summarizes known
variation in LE, LS and LT proteins. Ser, Thr, and Tyr sites predicted by any online
phosphorylation algorithm are highlighted ( ). Sites selected for mutagenesis
( ) are a subset and include also zinc-ﬁnger disruption mutations ( ). Mapped
phosphorylation sites from this study (LS, LT) and others (LE) are in orange.
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Fig. 2. LX phosphorylation in cytosol. LT-GST (A) or LS-GST (B) proteins were
incubated with HeLa cytosol and [γ-32P]-ATP. After GST extraction and SDS-PAGE,
the proteins were detected by autoradiography (32P), or Western analysis (αGST).
After densitometry, the signals were normalized to the GST control (“0”) and wt
(“100”) samples. The uppermost αGST band is the fusion protein. (C) Equivalent
cytosol samples (HeLa, BHK) to A and B were probed byWestern analysis for AMPK,
CK2 and tubulin signals, relative to a standardized sample of rAMPK.
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times less efﬁciently than wt. The T40A and T58A had reduced label
incorporation by about 25%. The most active LS-GST sequences were
wt and Y34F.
LX-GST phosphorylation by rAMPK
For LE, disruption of the zinc ﬁnger domain at C19 unfolds the
protein, as measured by single-proton NMR, and renders it
inactive as substrate for reactions with cytosol or recombinant
kinases (Bacot-Davis and Palmenberg, 2013). The C11 in LT or LS is
the structural analog to LE C19 with presumably similar functions.
Indeed, neither Theilovirus protein with this mutation was
strongly labeled in Hela cytosol. Given the inability to discriminate
between structural and phosphorylation phenotypes at Y7, this
location was noted, but not pursued further.
Instead, the S57 site of LT-GST, the only other potent mutation for
this protein, was suggested by the algorithms as a potential target
for AMP-kinase, a ubiquitous sensor of cellular energy homeostasis,
and an enzyme common to all organisms from yeast to mammals.
AMPK is involved in the replication cycles of many viruses (for
review, see Mankouri and Harris (2011)). Recombinant AMPK was
active with each of the wt LX-GST proteins but not with GST control
(Fig. 3A). Surprisingly, LE-GST reacted even more strongly than
LT-GST or LS-GST, an unexpected ﬁnding since neither of the
mapped LE-GST sites (Y41, T47) had been previously assigned to this
enzyme (Basta et al., 2014). Parallel reactions with mutant proteins
conﬁrmed that AMPK was selecting the same LE site (T47) as the
previously mapped CK2 activity (Fig. 3B).
For LT-GST, mutation at S57, but not T63, also abolished AMPK
reactivity (Fig. 3D). The LT-dependent apoptotic phenotypes
(Stavrou et al., 2011), and LT intracellular localization differences
(Taniura et al., 2009) previously assigned to the S57 (DA) and P57
(GDVII) sequences are now logically explained by the phosphoryla-
tion status of this residue. We do not yet know if GDVII or other
viruses of this subtype use an alternative primary site instead. There
was no evidence in cytosol experiments (Hela or BKH, not shown)
that BeAn LT-T63 was a viable, reactive site (Fig. 2A), and certainly it
was unreactive with rAMPK (Fig. 3D). With the LS-GST protein,
mutation at T58 but not T63 also prevented rAMPK reactions
(Fig. 3C). The selection of this subset of proteins for testing was
based on the site-prediction algorithms, as these were the only LX
sites that ﬁt the enzyme proﬁle.
AMPK in cells
With standard reaction conditions, 50 ng of rAMPK put an
average of 1 phosphate onto each substrate LE-GST protein (not
shown). The cytosol reactions with the same amount of substrate
usually required longer exposures, suggesting a lower saturation of
label. When tested side-by-side for antibody-band signals, relative
to rAMPK, a sample of HeLa cell lysate registered about 27 ng of
enzyme, as present in similar reactions (Fig. 3). BHK extracts gave
a higher concentration, so there is variability in the availability of
AMPK in these cell types. This means that native AMPK is probably
not a dominant, high concentration enzyme in HeLa cells. The
alternative possibility that LS-GST (and LT-GST, LE-GST) is perhaps a
non-ideal substrate is not supported by the incorporation data.
The listed speciﬁc activity for rAMPK on its preferred acetyl-CoA
carboxylase substrate is 737 nmol/min/mg, a value that should
label 2 μg of LS-GST (62 pmol) within 3–5 min, as was observed
in the actual reactions.
Structure prediction
The Theilo and Ser/Thr domains of LS-GST and LT-GST contain
the respective T58 and S57 mutation-mapped AMPK phosphoryla-
tion sites for these proteins (Fig. 1). These sites are not homologs
because the alignments place the LS S57 within the context of the
Theilo domain, paired vertically with LT T63, a non-phosphorylated
site. Unique to the Theilovirus proteins, however, the sequences
within both inserted domains uniformly show strong, conserved
patterns of 3–4 amino acid periodicities (e.g. Ser/Thr, Asp/Gly,
Leu/Val). Such patterns typically identify strong α-helical regions.
When queried with the Lasergene Protean Suite, every algorithm
concurred on this conﬁguration for the short (4 turn, LS), or
longer (7 turn, LT) insertions. If this model is true, as depicted in
Fig. 4, the central helical portions, scaled to the determined LM
structure, would place both Theilovirus AMPK sites virtually on
top of each other, a proximity dictated by the respective helical
folds. The Ser/Thr domain (e.g. LT) then would behave physically
just like an extended Theilo domain (e.g. LS), with a consequently
displaced AMPK site. The LT residue T63, the sequence homolog
to LS T58 was not phosphorylated by AMPK. That activity is
apparently shifted upstream, by 2 turns of the putative helix, to
the structural analog, S57. Possibly, the adjacent proximity to
the upstream acidic domain plays a role in this site selection.
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Fig. 3. Phosphorylation of LX-GST by rAMPK. Recombinant GST and LX-GST proteins
were reacted with rAMPK (50 ng) and [γ-32P]-ATP as in Methods. After pulldown
and protein fractionation, gel bands were detected by phosphoimaging (32P) and
silver stain, or after transfer to membranes, by Western analyses (αGST). The
phosphorylation signals as measured by densitometry were normalized (norm) to
the top band (full-length fusion protein) of LE-GST (A, B) LS-GST (C), or LT-GST (D)
αGST signal. Other GST-reactive bands in these panels are from inappropriate LX
translational start sites during bacterial protein expression.
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Fig. 4. Structure models. An LM conﬁguration as determined by NMR (PDB: 2M7Y)
shows the location of Theilovirus Ser/Thr and Theilo domain insertions, modeled
here as helices. Within these contexts, the mapped LT and LS AMPK sites occupy
analogous locations relative to the start of each helix.
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The LE-GST primary site, recognized by CK2 or AMPK, is just on the
other side of this acidic patch, again suggesting an analogous if not
homologous function.
Conclusions
Why do cardiovirus LX use different phosphorylation sites
when the end goal of nucleocytoplasmic trafﬁcking inhibition is
the same? Perhaps phosphorylation variability could just be fallout
of cell-type preference by EMCV, Saffold, and TMEV, i.e. each
virus type has adapted to use a kinase abundant in their cell type
of choice. Alternatively, the site selection and required kinase
(s) could represent distinct regulatory methods. LE from highly
virulent EMCV is phosphorylated by the highly expressed and
constitutively active CK2 and also at the same site, by AMPK, an
enzyme which is less abundant in some cell types. The Theilo-
viruses, however, are not as robust in their host range, and at least
for the sites mapped here seem to rely on AMPK and not CK2,
possibly slowing the viral lifecycle in a way that is helpful for the
establishment of persistence. The LT site for AMPK, S57, is a known
determinant distinguishing between persistent demyelinating
strains of TMEV (DA, BeAn) and neurovirulent strains (GDVII).
Recombinant conversion of DA S57 to P57 results in a GDVII
phenotype (high titer, large plaques) in BHK-21 cells, while the
opposite conversion (GDVII P57 to S57) gives a DA phenotype (low
titer, small plaques) (Takano-Maruyama et al., 2006). Apoptotic
phenotypes are also localized to this residue (Stavrou et al., 2011).
RanGTPase binding is ubiquitous to all cardiovirus L proteins, but
the phosphorylation status of the LX apparently does not con-
tribute to this step (Bacot-Davis and Palmenberg, 2013). Therefore,
LX phosphorylation must be required for the subsequent ternary
(or quaternary?) complexes that actually carry out Nup phosphor-
ylation. Differential partner selection after Ran binding is logical
experimental directions predicted by these ﬁndings.
Materials and methods
Plasmids and proteins
Bacterial plasmids pLE-GST, pLS-GST and pLT-GST and select
point mutations were prepared as described (Basta et al., 2014)
using site-directed mutagenesis via PCR overlap extension meth-
ods (Ho et al., 1989). We thank Dr. Howard Lipton for the generous
gift of SafV-2 and TMEV (BeAn) cDNA starting materials. The
matched panels linked the LX gene(s) upstream, in-frame with a
glutathione S-transferase gene (GST) in a context that allowed
direct cDNA transfection, transcription (via a CMV promoter) and
expression in eukaryotic cells. LX-GST fusion proteins were
expressed in bacteria and puriﬁed on Glutathione Sepharose High
Performance Column (GE Healthcare Life Sciences) as described
(Cornilescu et al., 2008). Proteins prepared this way can have
smaller αGST-reactive bands in addition the full-length fusion,
because of alternative bacterial translation start sites in the LX
genes (Basta et al., 2014).
Phosphorylation assays
HeLa or BHK cytosol was prepared via dounce homogenization
(Watters and Palmenberg, 2011). Phosphorylation reactions (80 μl
total, with 30 μl cytosol, 2 μl 10 mM ATP, 2 μg LX-GST, 0.75 μl
[γ-32P]-ATP) were in GST binding buffer (50 mM HEPES, 150 mM
NaCl, 0.5% NP40, pH 7.4) for 45 min (37 1C). Glutathione sepharose
4B beads (10 μl per sample, GE Healthcare Life Sciences) were then
added, followed by agitation (4 1C, 2 h). The beads were collected
by centrifugation (500g), washed with GST buffer (4 ) and then
boiled in SDS gel loading buffer. Protein fractionation was by SDS-
PAGE (8% or 10%) with band visualization by phosphorimaging
(Typhoon 9200 Variable Mode Imager, GE Healthcare), silver stain,
or western analysis.
rAMPK (α1, β1, γ1) was obtained commercially (SignalChem).
Speciﬁc activity information was from the technical data sheet.
Reactions were similar to those described (Basta et al., 2014).
Puriﬁed LX-GST in buffer (10 μl, 2 μl 0.5 mM AMP, 1 μl 50 ng/μl
AMPK, 2 μg LX-GST, 25 mM MOPS pH 7.2, 25 mM MgCl2, 5 mM
EGTA, 2 mM EDTA, 0.25 mM DTT) was allowed to react with 2 μl
AMPK assay cocktail (0.25 mM ATP, 0.167 μCi/μl [γ-32P]-ATP) for
15 min, 30 1C. The LX-GST protein was extracted with glutathione
beads, washed and then fractionated by SDS-PAGE. Phosphoryla-
tion signals were quantiﬁed by densitometry using TotalLab Quant
(Nonlinear Dynamics Ltd., Newcastle, UK), normalizing to input
protein (from Western analysis or silver stain).
Western analyses
Protein bands were electrotransferred to polyvinylidene
diﬂuoride membranes and treated with primary and secondary
antibodies as described (Basta et al., 2014). The primary antibodies
included: αGST (murine mAb, 71087, Novagen), αCK2 (rabbit pAb,
06-873, Millipore), αtubulin (murine mAb, T4026, Sigma-Aldrich),
and αP-AMPK 23A3 (rabbit mAb, 2603, Cell Signaling).
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